Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Molecular MRD status and outcome after transplantation in NPM1-mutated AML.

Journal article

Dillon R. et al, (2020), Blood, 135, 680 - 688

Twenty five years of UK trials in acute myeloid leukaemia: what have we learned?

Journal article

Burnett AK. et al, (2020), Br J Haematol, 188, 86 - 100

Mechanisms of tyrosine kinase inhibitor resistance in chronic myeloid leukemia

Conference paper

Eiring AM. et al, (2019), CANCER RESEARCH, 79

Real world data and the art of maintenance therapy.


Hills RK., (2019), Br J Haematol, 184, 493 - 494

Potential benefit of higher dose daunorubicin in patients harbouring a FLT3-ITD mutation: Updated results of the AML17 trial

Journal article

Russell NH. et al, (2018), British Journal of Haematology, 173, 9 - 9

Load More